midpage
215 F. Supp. 3d 209
E.D.N.Y.
2016

Try one of our plugins.

Chat with this case or research any legal issue with our plugins for Claude, ChatGPT, Perplexity, or Harvey.

ClaudeChatGPTPerplexity
Read the full case

Background

  • Plaintiffs (consumers) brought a putative nationwide class action against Pfizer alleging "slack-fill" in Advil OTC packaging — that packaging size misled them into buying product because containers were not filled to capacity.
  • Claims asserted under the FDCA and New York, Florida, and California consumer protection laws; plaintiffs later withdrew the federal jurisdiction claim, leaving CAFA/diversity jurisdiction invoked in federal court.
  • Complaint acknowledged the pill-count is clearly and prominently printed on each package, but alleged plaintiffs relied on package size rather than the stated pill count.
  • Pfizer moved to dismiss under Rule 12(b)(6) and to strike the nationwide class, arguing lack of plausible deception, failure to plead injury/causation/reliance, failure of negligent-misrepresentation and unjust enrichment claims, and preemption.
  • The district court held plaintiffs failed as a matter of law to plausibly allege that a reasonable consumer would be misled given the unambiguous, prominent pill-count on the label, and also concluded plaintiffs could not meet CAFA’s amount-in-controversy requirement because they alleged no compensable injury.
  • Conclusion: Motion to dismiss granted and case dismissed for failure to state a claim and lack of subject-matter jurisdiction under CAFA/amount-in-controversy principles.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Whether packaging was "likely to mislead" a reasonable consumer Plaintiffs: package size created an expectation the container would be filled; consumers relied on size rather than label pill-count Pfizer: pill-count is clearly and prominently labeled; reasonable consumers would read the label and not be misled by package size Court: Dismissed — as a matter of law reasonable consumers would not be misled given the clear pill-count; claims implausible
Whether plaintiffs adequately alleged reliance, causation, and injury Plaintiffs: reliance on package size caused purchase and injury Pfizer: plaintiffs received the quantity listed; no actual injury or reliance on a misrepresentation Court: Dismissed — plaintiffs admitted they received the number of pills listed; no actionable injury or reasonable reliance
Whether negligent misrepresentation and unjust enrichment claims survive Plaintiffs: packaging practice supports these claims Pfizer: legal elements unmet because no misrepresentation or injury Court: Dismissed — underlying deception claim fails, so these ancillary claims fail
Whether CAFA diversity jurisdiction exists (amount in controversy) Plaintiffs: invoked CAFA to bring nationwide class Pfizer: plaintiffs cannot meet the $5M amount-in-controversy because no compensable damages alleged Court: Dismissed for lack of subject-matter jurisdiction — plaintiffs cannot show damages to meet CAFA threshold

Key Cases Cited

  • Bell Atl. Corp. v. Twombly, 550 U.S. 544 (plausibility standard for Rule 12(b)(6))
  • Ashcroft v. Iqbal, 556 U.S. 662 (application of plausibility pleading standards)
  • St. Paul Mercury Indem. Co. v. Red Cab Co., 303 U.S. 283 (amount-in-controversy legal certainty rule)
  • Fink v. Time Warner Cable, 714 F.3d 739 (reasonable-consumer standard in consumer protection claims)
  • Freeman v. Time, Inc., 68 F.3d 285 (reasonable-consumer objective test)
  • L-7 Designs, Inc. v. Old Navy, LLC, 647 F.3d 419 (court may dismiss implausible consumer claims; rejecting conclusory allegations)
  • Haskell v. Time, Inc., 857 F. Supp. 1392 (standing for "non-actionable puffery" in packaging claims)
  • Prohias v. Pfizer, Inc., 485 F. Supp. 2d 1329 (no actionable injury where plaintiff received what was bargained for)
Read the full case

Case Details

Case Name: Fermin v. Pfizer Inc.
Court Name: District Court, E.D. New York
Date Published: Oct 18, 2016
Citations: 215 F. Supp. 3d 209; 2016 U.S. Dist. LEXIS 144851; 2016 WL 6208291; 15 CV 2133 (SJ) (ST)
Docket Number: 15 CV 2133 (SJ) (ST)
Court Abbreviation: E.D.N.Y.
Log In